Adipose tissue and muscle attenuation as novel biomarkers predicting mortality in patients with extremity sarcomas

European Radiology

Volumn 26, Issue 12, 2016, Pages 4649-4655

  Veld, Joyce ^a   Vossen, Josephina A ^a   De Amorim Bernstein, Karen ^a   Halpern, Elkan F ^a   Torriani, Martin ^a   Bredella, Miriam A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adipose tissue attenuation; Computed tomography (CT); Hounsfield Units; Muscle attenuation; Sarcoma

Indexed keywords

BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER MORTALITY; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; IMAGING SOFTWARE; INTRAPERITONEAL FAT; LIMB TUMOR; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PSOAS MUSCLE; RADIATION ATTENUATION; RETROSPECTIVE STUDY; SEX; STATISTICAL ANALYSIS; WHOLE BODY IMAGING; DIAGNOSTIC IMAGING; LIMB; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; SARCOMA; SOFT TISSUE TUMOR; X-RAY COMPUTED TOMOGRAPHY;

ABDOMINAL FAT; BIOMARKERS; EXTREMITIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSOAS MUSCLES; RETROSPECTIVE STUDIES; SARCOMA; SOFT TISSUE NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84960112354     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-016-4306-6     Document Type: Article

References (39)

1. Stiller CA, Trama A, Serraino D et al (2013) Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project. Eur J Cancer 49:684–695
2. Morrison BA (2003) Soft tissue sarcomas of the extremities. Proc (Baylor Univ Med Cent) 16:285–290
3. Tzeng CW, Smith JK, Heslin MJ (2007) Soft tissue sarcoma: preoperative and postoperative imaging for staging. Surg Oncol Clin N Am 16:389–402
4. Dirat B, Bochet L, Dabek M et al (2011) Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res 71:2455–2465
5. Nieman KM, Romero IL, Van Houten B, Lengyel E (1831) Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013:1533–1541
6. Andarawewa KL, Motrescu ER, Chenard MP et al (2005) Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. Cancer Res 65:10862–10871
7. Martinez-Outschoorn UE, Sotgia F, Lisanti MP (2012) Power surge: supporting cells "fuel" cancer cell mitochondria. Cell Metab 15:4–5
8. Boutin RD, Yao L, Canter RJ, Lenchik L (2015) Sarcopenia: current concepts and imaging implications. AJR Am J Roentgenol 205:W255–W266
9. Martin L, Birdsell L, Macdonald N et al (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547
10. Murphy RA, Register TC, Shively CA et al (2014) Adipose tissue density, a novel biomarker predicting mortality risk in older adults. J Gerontol A Biol Sci Med Sci 69:109–117
11. Rosenquist KJ, Massaro JM, Pedley A et al (2015) Fat quality and incident cardiovascular disease, all-cause mortality and cancer mortality. J Clin Endocrinol Metab 100:227–234
12. Dahlman I, Mejhert N, Linder K et al (2010) Adipose tissue pathways involved in weight loss of cancer cachexia. Br J Cancer 102:1541–1548
13. Mracek T, Stephens NA, Gao D et al (2011) Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 104:441–447
14. Rolland Y, Abellan van Kan G, Gillette-Guyonnet S, Vellas B (2011) Cachexia versus sarcopenia. Curr Opin Clin Nutr Metab Care 14:15–21
15. Di Sebastiano KM, Yang L, Zbuk K et al (2013) Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr 109:302–312
16. Fujiwara N, Nakagawa H, Kudo Y et al (2015) Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma. J Hepatol 63:131–140
17. Miljkovic I, Kuipers AL, Cauley JA et al (2015) Greater skeletal muscle fat infiltration is associated with higher all-cause and cardiovascular mortality in older men. J Gerontol A Biol Sci Med Sci 70:1133–1140
18. Tamandl D, Paireder M, Asari R et al () Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer. Eur Radiol
19. Vettor R, Milan G, Franzin C et al (2009) The origin of intermuscular adipose tissue and its pathophysiological implications. Am J Physiol Endocrinol Metab 297:E987–E998
20. Zoico E, Rossi A, Di Francesco V et al (2010) Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level. J Gerontol A Biol Sci Med Sci 65:295–299
21. Fujiki H, Sueoka E, Suganuma M (2013) Tumor promoters: from chemicals to inflammatory proteins. J Cancer Res Clin Oncol 139:1603–1614
22. Bredella MA, Gill CM, Rosen CJ et al (2014) Positive effects of brown adipose tissue on femoral bone structure. Bone 58:55–58
23. Shen W, Punyanitya M, Wang Z et al (2004) Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image. J Appl Physiol 97:2333–2338
24. Borkan GA, Gerzof SG, Robbins AH et al (1982) Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36:172–177
25. Maurovich-Horvat P, Massaro J, Fox CS et al (2007) Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes (Lond) 31:500–506
26. Bramer JA, van Linge JH, Grimer RJ, Scholten RJ (2009) Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol 35:1030–1036
27. Kang S, Kim HS, Kim W et al (2015) Comorbidity is independently associated with poor outcome in extremity soft tissue sarcoma. Clin Orthop Surg 7:120–130
28. Pakos EE, Nearchou AD, Grimer RJ et al (2009) Prognostic factors and outcomes for osteosarcoma: an international collaboration. Eur J Cancer 45:2367–2375
29. Brennan MF, Antonescu CR, Moraco N, Singer S (2014) Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg 260:416–421, discussion 421-412
30. Mullen JT, Hornicek FJ, Harmon DC et al (2014) Prognostic significance of treatment-induced pathologic necrosis in extremity and truncal soft tissue sarcoma after neoadjuvant chemoradiotherapy. Cancer 120:3676–3682
31. Choi YY, Kim JY, Yang SO (2014) PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions. Semin Musculoskelet Radiol 18:133–148
32. Sheikhbahaei S, Marcus C, Hafezi-Nejad N et al (2015) Value of FDG PET/CT in patient management and outcome of skeletal and soft tissue sarcomas. PET Clin 10:375–393
33. Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862–871
34. Goodpaster BH, Kelley DE, Thaete FL et al (2000) Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) 89:104–110
35. Yip C, Goh V, Davies A et al (2014) Assessment of sarcopenia and changes in body composition after neoadjuvant chemotherapy and associations with clinical outcomes in oesophageal cancer. Eur Radiol 24:998–1005
36. Kelley DE, Goodpaster BH (2001) Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diabetes Care 24:933–941
37. Goodpaster BH, Carlson CL, Visser M et al (2001) Attenuation of skeletal muscle and strength in the elderly: the health ABC study. J Appl Physiol (1985) 90:2157–2165
38. Lang T, Cauley JA, Tylavsky F et al (2010) Computed tomographic measurements of thigh muscle cross-sectional area and attenuation coefficient predict hip fracture: the health, aging, and body composition study. J Bone Miner Res 25:513–519
39. Gupta D, Lis CG (2010) Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J 9:69